These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1241913)

  • 1. Supersensitivity to dopaminergic agonists induced by haloperidol.
    Thornburg JE; Moore KE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):23-8. PubMed ID: 1241913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels.
    Antkiewicz-Michaluk L; Karolewicz B; Michaluk J; Vetulani J
    Eur J Pharmacol; 1995 Dec; 294(2-3):459-67. PubMed ID: 8750706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
    Tulunay FC; Sparber SB; Takemori AE
    Eur J Pharmacol; 1975 Aug; 33(1):65-70. PubMed ID: 1175692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
    Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
    Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R; Jackson DM
    Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1983; 14(5):545-7. PubMed ID: 6685669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine.
    Nahorski SR
    Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.